Literature DB >> 2524464

In vitro immunosuppressive properties of spergualins to murine T cell response.

H Fujii1, T Takada, K Nemoto, F Abe, A Fujii, T Takeuchi.   

Abstract

Deoxyspergualin has strong immunosuppressive activity in animals. However, it shows less in vitro immunosuppressive activity at the therapeutic concentration used for in vivo administration. Recently, we reported that there are some technical problems with in vitro experiments. In this report, the effects of spergualins were examined under in vitro conditions which excluded these problems, and compared with cyclosporine A (CYA). Spergualins have suppressive effects on mixed lymphocyte response (MLR) and cytotoxic T lymphocyte induction. Furthermore, interleukin-2 (IL-2) induced proliferation of concanavalin A blasts and CTLL-2 were inhibited at low concentration. However, spergualins have little effect in the early stage of MLR or the mitogen response. These results suggest that spergualins act on the proliferation and differentiation of T cells which respond to growth factors, such as IL-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524464     DOI: 10.7164/antibiotics.42.788

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

2.  Immunosuppressant deoxyspergualin induces apoptotic cell death in dividing cells.

Authors:  C Odaka; E Toyoda; K Nemoto
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

3.  Deoxyspergualin, an immunosuppressant, in patients suffering from nephropathies with crescent formation: an open-label trial to evaluate safety and efficacy.

Authors:  Hirokazu Imai; Osamu Hotta; Mitsuhiro Yoshimura; Tsuneo Konta; Yoshiharu Tsubakihara; Masanobu Miyazaki; Chie Tomida; Masaki Kobayashi; Satoshi Suzuki; Hideo Shiiki; Atsushi Yamauchi; Hitoshi Yokoyama; Masato Nose
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

4.  Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model.

Authors:  M Tsugita; L A Valdivia; A S Rao; F Pan; S Celli; A J Demetris; J J Fung; T E Starzl
Journal:  Transplantation       Date:  1996-06-27       Impact factor: 4.939

5.  Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.

Authors:  S Jung; K V Toyka; H P Hartung
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

6.  Cytostatic effect of deoxyspergualin on a murine leukemia cell line L1210.

Authors:  M Hiratsuka; H Kuramochi; K Takahashi; T Takeuchi; M Oshimura
Journal:  Jpn J Cancer Res       Date:  1991-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.